Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Deferred Taxes: 2021-2025

Historic Deferred Taxes for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Sep 2025 value amounting to $4.2 million.

  • Kiniksa Pharmaceuticals International's Deferred Taxes rose 216.16% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 146.49%. This contributed to the annual value of $8.1 million for FY2024, which is 124.07% up from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Deferred Taxes is $4.2 million, which was up 59.87% from $2.6 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Deferred Taxes ranged from a high of $10.6 million in Q2 2024 and a low of -$25.7 million during Q4 2023.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Deferred Taxes averaged around -$1.4 million, with its median value being $2.6 million (2025).
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Deferred Taxes crashed by 7,487.64% in 2023, and later soared by 305.29% in 2024.
  • Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Deferred Taxes stood at $10,000 in 2021, then reached $348,000 in 2022, then plummeted by 7,487.64% to -$25.7 million in 2023, then surged by 87.70% to -$3.2 million in 2024, then skyrocketed by 216.16% to $4.2 million in 2025.
  • Its Deferred Taxes was $4.2 million in Q3 2025, compared to $2.6 million in Q2 2025 and $3.0 million in Q1 2025.